- Helps lower blood sugar levels in adults with type 2 diabetes.
- Reduces the risk of cardiovascular events in patients with type 2 diabetes and established cardiovascular disease.
- Promotes weight loss by increasing glucose excretion through urine.
- Improves glycemic control when used in conjunction with diet and exercise.
- May help reduce blood pressure in some patients.
- Can be used as monotherapy or in combination with other antidiabetic medications.
- Supports kidney health by reducing the progression of diabetic kidney disease.
Empa Cad 25 Tablet - Strip of 10
Compositions : Empagliflozin 25mg
MRP :
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Shrrishti Health Care Products Pvt Ltd
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Empa Cad 25 Tablet is a pharmaceutical product primarily used in the management of type 2 diabetes mellitus. This medication contains the active ingredient Empagliflozin, which belongs to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. Empagliflozin works by preventing the reabsorption of glucose in the kidneys, leading to increased glucose excretion through urine. This mechanism not only helps in lowering blood sugar levels but also contributes to weight loss and has beneficial effects on cardiovascular health. The formulation of Empa Cad 25 Tablet is designed to provide effective glycemic control for patients with type 2 diabetes, making it a vital component of diabetes management plans. It is often prescribed alongside lifestyle modifications such as diet and exercise to achieve optimal blood glucose levels. The tablet is typically taken once daily, and its efficacy has been supported by various clinical studies demonstrating its role in reducing the risk of cardiovascular events in diabetic patients. Overall, Empa Cad 25 Tablet serves as an essential therapeutic option for individuals seeking to manage their diabetes effectively while also addressing associated health risks.
Product Details
- Empagliflozin inhibits the SGLT2 protein in the kidneys, which is responsible for glucose reabsorption.
- This inhibition leads to increased glucose excretion in urine, thereby lowering blood glucose levels.
- By reducing blood sugar levels, it helps improve overall glycemic control.
- Empagliflozin also promotes osmotic diuresis, which can lead to weight loss and lower blood pressure.
- The drug has been shown to have protective effects on the cardiovascular system in diabetic patients.
- The recommended dosage of Empa Cad 25 Tablet is one tablet taken orally once daily.
- It can be taken with or without food, but it is advisable to take it at the same time each day for consistency.
- Patients should follow their healthcare provider's instructions regarding dosage adjustments based on individual response and tolerability.
- Do not exceed the prescribed dose without consulting a healthcare professional.
- If a dose is missed, take it as soon as remembered unless it is close to the time for the next dose; do not double up on doses.
- Regular monitoring of blood glucose levels is recommended to assess the effectiveness of the treatment.
- Maintain a balanced diet rich in whole grains, fruits, vegetables, and lean proteins to support diabetes management.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise per week.
- Monitor blood sugar levels regularly to understand how food and activity affect your glucose levels.
- Stay hydrated by drinking plenty of water throughout the day.
- Avoid excessive alcohol consumption, as it can affect blood sugar levels and interact with medications.
- Work closely with healthcare providers to adjust your treatment plan as needed based on lifestyle changes and health status.
Safety Advice
Side Effects
- Common side effects include:
- Increased urination
- Urinary tract infections
- Genital fungal infections
- Serious side effects may include:
- Ketoacidosis (high levels of ketones in the blood)
- Severe dehydration
- Kidney problems
- If you experience symptoms such as nausea, vomiting, abdominal pain, or difficulty breathing, seek medical attention immediately.
Precautions and Warnings
- Do not use Empa Cad 25 Tablet if you have severe kidney disease or are on dialysis.
- Consult your doctor before using this medication if you have a history of urinary tract infections or dehydration.
- Avoid alcohol consumption while taking this medication due to potential interactions.
- Pregnant or breastfeeding women should discuss risks and benefits with their healthcare provider before use.
- Monitor kidney function regularly while on this medication.
- If you experience symptoms of ketoacidosis such as nausea or abdominal pain, seek medical help immediately.
FAQs
If you miss a dose, take it as soon as you remember unless it's almost time for your next dose. Do not take two doses at once.
2. Can I take Empa Cad 25 Tablet if I am pregnant?
Empa Cad 25 Tablet is not recommended during pregnancy. Consult your healthcare provider for alternatives.
3. Are there any food interactions with Empa Cad 25 Tablet?
There are no specific food interactions, but maintaining a balanced diet is crucial for managing diabetes.
4. What are the common side effects of Empa Cad 25 Tablet?
Common side effects may include urinary tract infections, genital fungal infections, and increased urination.
5. Who should avoid taking Empa Cad 25 Tablet?
Individuals with severe kidney impairment or those on dialysis should avoid this medication.
6. How should I store Empa Cad 25 Tablet?
Store the tablets at room temperature away from moisture and heat, and keep them out of reach of children.
Instructions
No content available for this section.
More Information
| SKU | 623976 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Shrrishti Health Care Products Pvt Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Empa Cad 25 Tablet is a pharmaceutical product primarily used in the management of type 2 diabetes mellitus. This medication contains the active ingredient Empagliflozin, which belongs to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. Empagliflozin works by preventing the reabsorption of glucose in the kidneys, leading to increased glucose excretion through urine. This mechanism not only helps in lowering blood sugar levels but also contributes to weight loss and has beneficial effects on cardiovascular health. The formulation of Empa Cad 25 Tablet is designed to provide effective glycemic control for patients with type 2 diabetes, making it a vital component of diabetes management plans. It is often prescribed alongside lifestyle modifications such as diet and exercise to achieve optimal blood glucose levels. The tablet is typically taken once daily, and its efficacy has been supported by various clinical studies demonstrating its role in reducing the risk of cardiovascular events in diabetic patients. Overall, Empa Cad 25 Tablet serves as an essential therapeutic option for individuals seeking to manage their diabetes effectively while also addressing associated health risks.
- Helps lower blood sugar levels in adults with type 2 diabetes.
- Reduces the risk of cardiovascular events in patients with type 2 diabetes and established cardiovascular disease.
- Promotes weight loss by increasing glucose excretion through urine.
- Improves glycemic control when used in conjunction with diet and exercise.
- May help reduce blood pressure in some patients.
- Can be used as monotherapy or in combination with other antidiabetic medications.
- Supports kidney health by reducing the progression of diabetic kidney disease.
- Empagliflozin inhibits the SGLT2 protein in the kidneys, which is responsible for glucose reabsorption.
- This inhibition leads to increased glucose excretion in urine, thereby lowering blood glucose levels.
- By reducing blood sugar levels, it helps improve overall glycemic control.
- Empagliflozin also promotes osmotic diuresis, which can lead to weight loss and lower blood pressure.
- The drug has been shown to have protective effects on the cardiovascular system in diabetic patients.
- The recommended dosage of Empa Cad 25 Tablet is one tablet taken orally once daily.
- It can be taken with or without food, but it is advisable to take it at the same time each day for consistency.
- Patients should follow their healthcare provider's instructions regarding dosage adjustments based on individual response and tolerability.
- Do not exceed the prescribed dose without consulting a healthcare professional.
- If a dose is missed, take it as soon as remembered unless it is close to the time for the next dose; do not double up on doses.
- Regular monitoring of blood glucose levels is recommended to assess the effectiveness of the treatment.
- Maintain a balanced diet rich in whole grains, fruits, vegetables, and lean proteins to support diabetes management.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise per week.
- Monitor blood sugar levels regularly to understand how food and activity affect your glucose levels.
- Stay hydrated by drinking plenty of water throughout the day.
- Avoid excessive alcohol consumption, as it can affect blood sugar levels and interact with medications.
- Work closely with healthcare providers to adjust your treatment plan as needed based on lifestyle changes and health status.
Side Effects
- Common side effects include:
- Increased urination
- Urinary tract infections
- Genital fungal infections
- Serious side effects may include:
- Ketoacidosis (high levels of ketones in the blood)
- Severe dehydration
- Kidney problems
- If you experience symptoms such as nausea, vomiting, abdominal pain, or difficulty breathing, seek medical attention immediately.
Precautions and Warnings
- Do not use Empa Cad 25 Tablet if you have severe kidney disease or are on dialysis.
- Consult your doctor before using this medication if you have a history of urinary tract infections or dehydration.
- Avoid alcohol consumption while taking this medication due to potential interactions.
- Pregnant or breastfeeding women should discuss risks and benefits with their healthcare provider before use.
- Monitor kidney function regularly while on this medication.
- If you experience symptoms of ketoacidosis such as nausea or abdominal pain, seek medical help immediately.
If you miss a dose, take it as soon as you remember unless it's almost time for your next dose. Do not take two doses at once.
2. Can I take Empa Cad 25 Tablet if I am pregnant?
Empa Cad 25 Tablet is not recommended during pregnancy. Consult your healthcare provider for alternatives.
3. Are there any food interactions with Empa Cad 25 Tablet?
There are no specific food interactions, but maintaining a balanced diet is crucial for managing diabetes.
4. What are the common side effects of Empa Cad 25 Tablet?
Common side effects may include urinary tract infections, genital fungal infections, and increased urination.
5. Who should avoid taking Empa Cad 25 Tablet?
Individuals with severe kidney impairment or those on dialysis should avoid this medication.
6. How should I store Empa Cad 25 Tablet?
Store the tablets at room temperature away from moisture and heat, and keep them out of reach of children.
No content available for this section.
| SKU | 623976 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Shrrishti Health Care Products Pvt Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account